Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
The gelatin market is projected to grow from $3.7B in 2023 to $5.1B by 2028 growing at a CAGR of 6.6% during the forecast period, according to a report by Research & Markets. Most tablets are coated with gelatin, and it is used in both hard and soft capsules.
read more
The fertility supplements market size is set to grow by $819.22M between 2021 and 2026 and register a CAGR of 7.53%, according to Technavio's report.
The fertility supplements market growth in the women segment will be significant during the forecast period. Infertility is a worldwide health issue that affects 20%-30% of women of reproductive age...
read more
Over the years, rising complexity of active pharmaceutical ingredients (APIs) has led to the development of a myriad of novel formulations that enable efficient drug delivery to the intended site of action. Nonetheless, the demand for oral solid dosage (OSD) forms, including tablets and capsules, remains unparalleled.
read more
The global oral anticoagulants market size was worth around $18B in 2021 and is predicted to grow to around $34.1B by 2028, with a compound annual growth rate (CAGR) of roughly 9.6% between 2022 and 2028, according to a report by Facts and Factors.
read more
Thermo Fisher Scientific is adding early development work for oral solid dose therapies to its Bourgoin, France site, enabling that location to address customers’ workflow from early drug development through commercial manufacturing.
read more
The global pet supplement market size was worth around $1.91B in 2022 and is predicted to grow to around $3.12B by 2030, with a compound annual growth rate (CAGR) of roughly 5.91% between 2023 and 2030, according to a report by Facts and Factors.
read more
Torrent Pharma has begun shipping the generic version of Xeris's Keveyis® (dichlorphenamide), 50mg tablets, following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application.
read more
The market for Polyvinylpyrrolidone (PVP) had a global size of $1785.65M in 2021, and it is predicted to show a revenue compound annual growth rate (CAGR) of 6.2% during the forecast period, according to a report by Research & Markets.
read more
The global oral anticoagulants market size was worth around USD 18 billion in 2021 and is predicted to grow to around USD 34.1 billion by 2028 with a compound annual growth rate (CAGR) of roughly 9.6% between 2022 and 2028, according to a report by Facts and Factors.
read more
The De-oiled Lecithin Market is estimated at $220M in 2023 and is projected to reach $321M by 2028, at a CAGR of 7.8% from 2023 to 2028 according to a report published by MarketsandMarkets™.
read more
Upsher-Smith announced the launch of Fluphenazine Hydrochloride Tablets, USP in 1 mg, 2.5 mg, 5 mg, and 10 mg strengths.
read more
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Colestipol Hydrochloride Tablets USP, 1 g.
read more
IBSA Pharma added three new dosage strengths of Tirosint® (levothyroxine sodium) capsules to treat hypothyroidism. The three new dosing options – 37.5, 44 and 62.5 micrograms – expand Tirosint's existing 12 options.
read more
Darling Ingredients, a company that turns food waste into sustainable products, completed the acquisition of Gelnex, a leading global producer of gelatin and collagen products on March 31.
read more
The nutraceutical contract manufacturing services market size is estimated to be $114.2B in 2022 and is expected to witness a CAGR of 12.01% during the forecast period 2023-2033, according to a report by Research & Markets.
read more